These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 25336921

  • 1. Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers.
    Lee J, Lee H, Jang K, Lim KS, Shin D, Yu KS.
    Drug Des Devel Ther; 2014; 8():1781-8. PubMed ID: 25336921
    [Abstract] [Full Text] [Related]

  • 2. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC, Almeida S, Filipe A, Neves R, Trabelsi F, Farré A.
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
    Iqbal M, Khuroo A, Batolar LS, Tandon M, Monif T, Sharma PL.
    Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic interaction between pitavastatin and valsartan: a randomized, open-labeled crossover study in healthy male Korean volunteers.
    Jung JA, Noh YH, Jin S, Kim MJ, Kim YH, Jung JA, Lim HS, Bae KS.
    Clin Ther; 2012 Apr; 34(4):958-65. PubMed ID: 22410289
    [Abstract] [Full Text] [Related]

  • 5. A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects.
    Jung JA, Lee SY, Kim JR, Ko JW, Jang SB, Nam SY, Huh W.
    Drug Des Devel Ther; 2015 Apr; 9():745-52. PubMed ID: 25767372
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers.
    Hedaya MA, Helmy SA.
    Clin Ther; 2013 Jun; 35(6):846-61. PubMed ID: 23795576
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics, tolerability, and safety of the single oral administration of AGSAV301 vs Exforge: a randomized crossover study of healthy male volunteers.
    Choi HY, Kim YH, Kim MJ, Noh YH, Lee SH, Bae KS, Lim HS.
    Am J Cardiovasc Drugs; 2014 Feb; 14(1):63-72. PubMed ID: 24174172
    [Abstract] [Full Text] [Related]

  • 8. An interaction study with cimetidine and the new angiotensin II antagonist valsartan.
    Schmidt EK, Antonin KH, Flesch G, Racine-Poon A.
    Eur J Clin Pharmacol; 1998 Feb; 53(6):451-8. PubMed ID: 9551704
    [Abstract] [Full Text] [Related]

  • 9. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
    He YL, Ligueros-Saylan M, Sunkara G, Sabo R, Zhao C, Wang Y, Campestrini J, Pommier F, Dole K, Marion A, Dole WP, Howard D.
    J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic profiles of hydrochlorothiazide alone and in combination with benazepril or valsartan in healthy Chinese volunteers: evaluation of the potential interaction.
    Jiang J, Tian L, Huang Y, Xie S, Xu L, Liu H, Li Y.
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):756-64. PubMed ID: 22122818
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
    Kim JE, Ki MH, Yoon IS, Cho HJ, Kim RS, Tae Kim G, Kim DD.
    Clin Ther; 2014 Feb 01; 36(2):273-9. PubMed ID: 24529292
    [Abstract] [Full Text] [Related]

  • 12. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
    Vaidyanathan S, Valencia J, Kemp C, Zhao C, Yeh CM, Bizot MN, Denouel J, Dieterich HA, Dole WP.
    Int J Clin Pract; 2006 Nov 01; 60(11):1343-56. PubMed ID: 17073832
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study.
    Kim Y, Son M, Lee D, Roh H, Son H, Chae D, Bahng MY, Park K.
    Clin Ther; 2013 Jul 01; 35(7):934-40. PubMed ID: 23870605
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
    Sunkara G, Reynolds CV, Pommier F, Humbert H, Yeh C, Prasad P.
    Curr Med Res Opin; 2007 Mar 01; 23(3):631-40. PubMed ID: 17355744
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.
    Czendlik CH, Sioufi A, Preiswerk G, Howald H.
    Eur J Clin Pharmacol; 1997 Mar 01; 52(6):451-9. PubMed ID: 9342580
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic Drug Interactions Between Amlodipine, Valsartan, and Rosuvastatin in Healthy Volunteers.
    Seong SJ, Ohk B, Kang WY, Gwon MR, Kim BK, Cho S, Yang DH, Lee HW, Yoon YR.
    Adv Ther; 2019 Jul 01; 36(7):1642-1656. PubMed ID: 31119689
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.
    Bhad P, Ayalasomayajula S, Karan R, Leon S, Riviere GJ, Sunkara G, Jarugula V.
    J Clin Pharmacol; 2011 Jun 01; 51(6):933-42. PubMed ID: 20852001
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic and pharmacodynamic interaction of single oral doses of valsartan and furosemide.
    Bindschedler M, Degen P, Flesch G, de Gasparo M, Preiswerk G.
    Eur J Clin Pharmacol; 1997 Jun 01; 52(5):371-8. PubMed ID: 9272406
    [Abstract] [Full Text] [Related]

  • 19. Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteers using a replicated crossover design.
    Séchaud R, Graf P, Bigler H, Gruendl E, Letzkus M, Merz M.
    Int J Clin Pharmacol Ther; 2002 Jan 01; 40(1):35-40. PubMed ID: 11837381
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A, Izquierdo I, Donado E, Antonijoan R, Peña J, Nadal T, Carbó ML, Merlos M, Barbanoj M.
    Clin Ther; 2008 Sep 01; 30(9):1639-50. PubMed ID: 18840369
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.